Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 13.29 BATS BZX Real-Time Price As of 1:17pm ET |  -2.52 / -15.94%Today’s Change | 5.70 Today|||52-Week Range 19.00 | +22.26% Year-to-Date |
Latest ARCT News | Press Releases
No recent news for Arcturus Therapeutics Holdings Inc.
Today’s Trading
| Previous close | 15.81 |
| Today’s open | 16.04 |
| Day’s range | 13.17 - 16.04 |
| Volume | 16,389 |
| Average volume (3 months) | 132,125 |
| Market cap | $239.2M |
Data as of 1:17pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | +0.47% |
| Earnings growth (this year) | -30.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +31.97% |
| P/E ratio | NM |
| Price/Sales | 6.31 |
| Price/Book | 9.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NERVMinerva Neuroscience... | +0.10 | +1.59% |
| ALBOAlbireo Pharma Inc | -0.39 | -2.36% |
| STROSutro Biopharma Inc | +0.09 | +0.91% |
| MNKDMannKind Corp | -0.02 | -2.35% |
Data as of 1:18pm ET, 03/30/2020
Financials
| Next reporting date | May 18, 2020 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $20.8M |
| Annual profit (last year) | -$26.0M |
| Net profit margin | -125.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
